These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
702 related items for PubMed ID: 8447724
1. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia. Homma Y, Kobayashi T, Yamaguchi H, Sakane H, Ozawa H, Matsuda M, Mikami Y, Mikami Y, Nakamura H. Artery; 1993; 20(1):1-18. PubMed ID: 8447724 [Abstract] [Full Text] [Related]
2. Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia. Homma Y, Ozawa H, Kobayashi T, Yamaguchi H, Sakane H, Mikami Y, Mikami Y, Nakamura H. Atherosclerosis; 1994 Apr; 106(2):191-201. PubMed ID: 8060379 [Abstract] [Full Text] [Related]
3. Effects of eicosapentaenoic acid on plasma lipoprotein subfractions and activities of lecithin:cholesterol acyltransferase and lipid transfer protein. Homma Y, Ohshima K, Yamaguchi H, Nakamura H, Araki G, Goto Y. Atherosclerosis; 1991 Nov; 91(1-2):145-53. PubMed ID: 1811549 [Abstract] [Full Text] [Related]
4. Specific reduction of plasma large, light low-density lipoprotein by a bile acid sequestering resin, cholebine (MCI-196) in type II hyperlipoproteinemia. Homma Y, Kobayashi T, Yamaguchi H, Ozawa H, Sakane H, Nakamura H. Atherosclerosis; 1997 Mar 21; 129(2):241-8. PubMed ID: 9105567 [Abstract] [Full Text] [Related]
5. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice. Berti JA, Amaral ME, Boschero AC, Nunes VS, Harada LM, Castilho LN, Oliveira HC. Metabolism; 2001 May 21; 50(5):530-6. PubMed ID: 11319713 [Abstract] [Full Text] [Related]
6. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia. Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R. Artery; 1982 May 21; 10(4):266-85. PubMed ID: 7181672 [Abstract] [Full Text] [Related]
8. Effects of probucol on plasma lipids, lipoproteins and parameters of high density lipoprotein metabolism. Wetterau JR, Combs KA, Albers HW, Lamkin G, Stein EA, Barnhart RL, Chi EM, Jackson RL, Harmony JA. Horm Metab Res; 1992 Jun 21; 24(6):289-96. PubMed ID: 1634195 [Abstract] [Full Text] [Related]
9. Effects of probucol on plasma lipoprotein subfractions and activities of lipoprotein lipase and hepatic triglyceride lipase. Homma Y, Moriguchi EH, Sakane H, Ozawa H, Nakamura H, Goto Y. Atherosclerosis; 1991 Jun 21; 88(2-3):175-81. PubMed ID: 1892484 [Abstract] [Full Text] [Related]
10. Mechanisms of high-density lipoprotein reduction after probucol treatment: changes in plasma cholesterol esterification/transfer and lipase activities. Chiesa G, Michelagnoli S, Cassinotti M, Gianfranceschi G, Werba JP, Pazzucconi F, Sirtori CR, Franceschini G. Metabolism; 1993 Feb 21; 42(2):229-35. PubMed ID: 8474321 [Abstract] [Full Text] [Related]
11. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase. Chung BH, Segrest JP, Franklin F. Atherosclerosis; 1998 Dec 21; 141(2):209-25. PubMed ID: 9862170 [Abstract] [Full Text] [Related]
12. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux. Guerin M, Egger P, Soudant C, Le Goff W, van Tol A, Dupuis R, Chapman MJ. Atherosclerosis; 2002 Aug 21; 163(2):287-96. PubMed ID: 12052475 [Abstract] [Full Text] [Related]
13. Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer. Franceschini G, Sirtori M, Vaccarino V, Gianfranceschi G, Rezzonico L, Chiesa G, Sirtori CR. Arteriosclerosis; 1989 Aug 21; 9(4):462-9. PubMed ID: 2751476 [Abstract] [Full Text] [Related]
14. Changes in high-density lipoprotein subfraction distribution and increased cholesteryl ester transfer after probucol. Sirtori CR, Sirtori M, Calabresi L, Franceschini G. Am J Cardiol; 1988 Jul 25; 62(3):73B-76B. PubMed ID: 3293417 [Abstract] [Full Text] [Related]
15. Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer. Matsuzawa Y, Yamashita S, Funahashi T, Yamamoto A, Tarui S. Am J Cardiol; 1988 Jul 25; 62(3):66B-72B. PubMed ID: 3394656 [Abstract] [Full Text] [Related]
16. Effects of hepatic HDL-related mRNAs on plasma prebeta HDL in cholesterol-fed rabbits. Sugano M, Makino N, Yanaga T. Artery; 1997 Jul 25; 22(4):182-205. PubMed ID: 9576025 [Abstract] [Full Text] [Related]
17. Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects. Lagrost L, Gandjini H, Athias A, Guyard-Dangremont V, Lallemant C, Gambert P. Arterioscler Thromb; 1993 Jun 25; 13(6):815-25. PubMed ID: 8499401 [Abstract] [Full Text] [Related]
18. Effects of simvastatin on plasma lipoprotein subfractions, cholesterol esterification rate, and cholesteryl ester transfer protein in type II hyperlipoproteinemia. Homma Y, Ozawa H, Kobayashi T, Yamaguchi H, Sakane H, Nakamura H. Atherosclerosis; 1995 Apr 24; 114(2):223-34. PubMed ID: 7605391 [Abstract] [Full Text] [Related]